Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Vivos Therapeutics, Inc. (VVOS) had Weighted-Average Shares Outstanding (Diluted) of 5.01M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$15.03M |
|
$-11.14M |
|
$6.01M |
|
$9.02M |
|
$26.20M |
|
$-11.17M |
|
$0.04M |
|
$-11.14M |
|
$-11.14M |
|
$-11.14M |
|
$-11.14M |
|
$-11.14M |
|
$-11.14M |
|
$-11.17M |
|
$-10.59M |
|
5.01M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
5.01M |
$-2.22 |
|
$-2.22 |
|
| Balance Sheet Financials | |
$7.47M |
|
$3.35M |
|
$7.81M |
|
$15.28M |
|
$4.98M |
|
-- |
|
$2.35M |
|
$7.33M |
|
$7.95M |
|
$4.74M |
|
$7.95M |
|
5.89M |
|
| Cash Flow Statement Financials | |
$-12.69M |
|
$-0.57M |
|
$17.88M |
|
$1.64M |
|
$6.26M |
|
$4.62M |
|
$0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
60.00% |
|
-74.32% |
|
-74.32% |
|
-70.45% |
|
-74.09% |
|
-74.09% |
|
$-13.26M |
|
-- |
|
-- |
|
-- |
|
0.98 |
|
-- |
|
34.96 |
|
10.44 |
|
-140.00% |
|
-234.89% |
|
-72.86% |
|
-140.00% |
|
$1.35 |
|
$-2.65 |
|
$-2.53 |
|